Evogene (EVGN) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.49 (-2.98%), Market cap $0.01B, 52-week low–high $0.70 ~ $2.26.
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-
Financial statements, price targets, institutional (13F) holdings and related news for Evogene are updated in real time on BlackAll Trade.
Evogene trades at $0.49 (-2.98%). Real-time quotes and charts are available on BlackAll Trade.
Evogene has a market cap of about $0.01B.
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Healt